- Report
- October 2025
- 194 Pages
Global
From €3125EUR$3,545USD£2,704GBP
€3472EUR$3,939USD£3,004GBP
- Report
- October 2025
- 190 Pages
Global
From €3125EUR$3,545USD£2,704GBP
€3472EUR$3,939USD£3,004GBP
- Report
- October 2025
- 250 Pages
Global
From €3958EUR$4,490USD£3,425GBP
- Report
- October 2025
- 196 Pages
Global
From €5157EUR$5,850USD£4,462GBP
- Report
- August 2025
- 522 Pages
Global
From €4363EUR$4,950USD£3,776GBP
- Report
- November 2024
- 130 Pages
Global
From €4099EUR$4,650USD£3,547GBP
- Report
- March 2025
- 150 Pages
Global
From €5245EUR$5,950USD£4,538GBP
- Report
- April 2025
- 120 Pages
Global
From €5245EUR$5,950USD£4,538GBP
- Report
- February 2025
- 302 Pages
Global
From €2962EUR$3,360USD£2,563GBP
€3702EUR$4,200USD£3,204GBP
- Report
- August 2025
- 186 Pages
Global
From €3125EUR$3,545USD£2,704GBP
€3472EUR$3,939USD£3,004GBP
- Report
- August 2025
- 180 Pages
Global
From €3125EUR$3,545USD£2,704GBP
€3472EUR$3,939USD£3,004GBP
- Report
- October 2025
- 189 Pages
Global
From €3125EUR$3,545USD£2,704GBP
€3472EUR$3,939USD£3,004GBP
- Report
- October 2025
- 250 Pages
Global
From €3958EUR$4,490USD£3,425GBP
- Report
- October 2025
- 250 Pages
Global
From €3958EUR$4,490USD£3,425GBP
- Report
- September 2025
- 250 Pages
Global
From €3958EUR$4,490USD£3,425GBP
- Report
- October 2025
- 370 Pages
Global
From €5157EUR$5,850USD£4,462GBP
- Report
- October 2025
- 172 Pages
Global
From €5157EUR$5,850USD£4,462GBP
- Report
- October 2025
- 166 Pages
Global
From €5157EUR$5,850USD£4,462GBP
- Report
- October 2025
- 162 Pages
Global
From €5157EUR$5,850USD£4,462GBP
- Report
- August 2025
- 188 Pages
Global
From €3967EUR$4,500USD£3,432GBP

Pharmaceutical Services Outsourcing (PSO) is a rapidly growing market within the pharmaceutical manufacturing industry. It involves the transfer of certain activities, such as drug development, clinical trials, and manufacturing, from pharmaceutical companies to third-party service providers. This allows pharmaceutical companies to focus on their core competencies while outsourcing non-core activities to specialized service providers. PSO also helps pharmaceutical companies reduce costs, increase efficiency, and improve quality.
The PSO market is segmented into drug development, clinical trials, and manufacturing services. Drug development services include pre-clinical and clinical research, regulatory affairs, and drug safety. Clinical trials services include clinical trial management, data management, and biostatistics. Manufacturing services include active pharmaceutical ingredient (API) manufacturing, finished dosage form (FDF) manufacturing, and packaging and labeling.
Notable companies in the PSO market include Parexel, Quintiles, Covance, PRA Health Sciences, and Charles River Laboratories. Show Less Read more